Biohimiâ

ISSN (print)0320-9725

Media registration certificate: ПИ № ФС77–71478 от 23.11.2017

Founder:  Russian Academy of Sciences

Editor-in-Chief: Dontsova Olga Anatolyevna, academician of the Russian Academy of Sciences, Professor, Doctor of Chemical Sciences

Number of issues per year: 12

Indexation:

Edição corrente

Acesso aberto Acesso aberto  Acesso é fechado Acesso está concedido  Acesso é fechado Somente assinantes

Volume 90, Nº 3 (2025)

Capa

Edição completa

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Articles

To the question of the dualism of neutrophils' role in the processes of carcinogenesis, as well as the possibility of cell application for malignant neoplasm therapy
Gabashvili A., Vasyukova A., Rakitina A., Garanina A.
Resumo

Neutrophils are phagocytic, myeloid-type leukocytes that are the most common myeloid cells in human blood, normally comprising 65 to 80% of all circulating leukocytes. Over the years of research into these cells, more and more evidence has emerged demonstrating the functional plasticity of neutrophils and their ambiguous role in tumor development. Similar to the M1/M2 classification of macrophages, the N1/N2 paradigm can be applied to neutrophils, where N1 neutrophils exhibit tumor-suppressive properties, while N2 neutrophils promote tumor development and suppression of immunity. An important natural feature of neutrophils is their mobility and ability to overcome physical barriers, which is why these cells, as well as their vesicles and membranes, can be used to deliver therapeutic drugs to tumor cells. Moreover, neutrophils themselves can be activated and mobilized to fight tumors. This review describes the current state of research into the role of neutrophils in carcinogenesis, as well as possible approaches to the use of these cells and their derivatives as delivery systems for therapeutic drugs for the treatment of malignant neoplasms.

Biohimiâ. 2025;90(3):335-354
pages 335-354 views
Interrelationship between non-vesicular transport of sterols and their distribution between rafts and the non-raft phase of the plasma membrane
Sokolov S., Zyrina A., Akimov S., Severin F.
Resumo

Sterols significantly affect the barrier properties of the membrane. This probably explains the fact that their concentration is maximal in the PM (plasma membrane). In combination with sphingolipids, sterols form rafts - bilayer regions whose physicochemical properties differ from those in the surrounding membrane. Thus, in the presence of rafts in the membrane, membrane proteins can choose the lipid environment optimal for their functioning, best suited in terms of thickness and rigidity of the bilayer, spontaneous curvature and lateral pressure profile. Sterols and sphingolipids in rafts are in ratios close to stoichiometric. Theoretically, excess sterol outside rafts can critically reduce the degree of ordering of phospholipid ordering. Sterols are synthesized in the endoplasmic reticulum (ER). An active, against the concentration gradient, transport of sterols from the ER to the PM is carried out by proteins of the Osh family. Lam proteins carry out passive reverse transport of sterols from the PM to the ER. Inactivation of Osh proteins does not reduce the total level of sterols in the PM, but, in an unclear way, reduces the rate of their movement inside the PM. Therefore, the vesicular transport of sterols from the ER to the PM is probably more active than the non-vesicular one carried out by Osh proteins. Since sterols are more firmly anchored in rafts than outside them, and are also sterically less accessible, we suggest that Lam proteins transport excess sterols from the non-raft phase of the PM to the ER, and Osh proteins return them to the PM. In this way, the rotation of sterols between the non-raft part of the PM and rafts can be driven, with the enrichment of the latter. It is possible that with a decrease in the concentration of sterol in the non-raft part of the membrane, the speed of the Lam proteins decreases since the degree of ordering of phospholipids and, consequently, the strength of retention of the sterol molecule in the membrane increases. It is possible that homeostasis of the concentration and distribution of sterol in the PM is maintained in this way.

Biohimiâ. 2025;90(3):355-369
pages 355-369 views
RAGE-mediated effects of formaldehyde on the course of Alzheimer’s disease
Mikhailov I., Mikhailova M., Shuvaev A., Gorina Y., Belozor O.
Resumo

To date, Alzheimer's disease (AD) is an incurable disease with enormous socioeconomic consequences. One of the known mechanisms of Alzheimer's disease pathogenesis is the deposition of amyloid plaques as a result of beta-amyloid (Aβ) accumulation. Receptor for glycation end products (RAGE) plays an important role in the transport of Aβ across the GEB. Also, ligand interaction with RAGE regulates the expression of amyloid precursor protein (APP), which plays a key role in Aβ accumulation. In this analytical review, we dissect the biochemical mechanism of toxic effects of exogenous formaldehyde in the hippocampus leading to the development of insulin resistance and further molecular mechanisms of neuroinflammation contributing to increased RAGE expression. Accumulation of endogenous formaldehyde in the body may occur as a result of impaired utilization. However, the accumulation associated with the ingestion of exogenous formaldehyde has much more acute and dangerous consequences. Formaldehyde is one of the main toxins, MAC of which is stably exceeded in many cities of Russia, as well as in countries of East, South and South-East Asia, Central Africa, North and South America. Formaldehyde plays a major role in the pathogenesis of neurodegenerative diseases, as its biochemical mechanism of action is closely related to increased Aβ accumulation. In individuals more susceptible to beta-amyloid accumulation (due to age or genetic predisposition), exposure to exogenous formaldehyde may have an additional effect on beta-amyloid accumulation. Experiments have previously been conducted investigating the role of formaldehyde in neurodegenerative diseases. A correlation was found between the degree of air pollution and hyperglycaemia. However, the detailed mechanism for the further development of neurodegeneration remains unclear. This review emphasizes the importance of studying the interaction between environmental toxins and neurodegenerative diseases, which may lead to the development of a therapeutic approach based on the protection of neurons from the effects of toxic substances in individuals susceptible to this pathology.

Biohimiâ. 2025;90(3):370-385
pages 370-385 views
Development of immunochemical systems for detection of human skeletal troponin i isoforms
Bogomolova A., Katrukha I., Emelin A., Zabolotsky A., Bereznikova A., Lebedeva O., Deev R., Katrukha A.
Resumo

Troponin I (TnI), together with troponin T and troponin C (TnC), forms the troponin complex, a thin filament protein of the striated muscle that plays a key role in the regulation of muscle contraction. In humans, TnI is represented by three isoforms: cardiac, which is synthesised only in the myocardium, and fast and slow skeletal, which are synthesised in fast- and slow-twitch muscle fibres, respectively. Skeletal TnI isoforms can be used as biomarkers of skeletal muscle damage of various aetiologies, including mechanical trauma, myopathies, muscle atrophy (sarcopenia), and rhabdomyolysis. Unlike classical markers of muscle damage, such as creatine kinase or myoglobin, which are also present in other tissues, skeletal TnIs are specific for skeletal muscle. In this study, we developed a panel of monoclonal antibodies for immunochemical detection of skeletal TnI isoforms in Western blotting (sensitivity: 0.01-1 ng per lane), in immunohistochemistry, and in fluorescence immunoanalysis. Some of the designed fluorescence immunoanalyses enable the quantification of fast skeletal (limit of detection [LOD]=0.07 ng/mL) and slow skeletal TnI (LOD=0.1 ng/mL) or both isoforms (LOD=0.1 ng/ml). Others allow the differential detection of binary (with TnC) or ternary (with troponin T and TnC) complexes, revealing the composition of troponin forms in human blood.

Biohimiâ. 2025;90(3):386-402
pages 386-402 views
Peripheral immune-inflammatory parameters of the Parkinson's disease. Dependence on the stage of progression
Idova G., Zhanaeva S., Alperina E., Dzemidovich S., Gevorgyan M., Kulikova K., Aftanas L.
Resumo

According to modern concepts, neuroinflammation and peripheral immune dysfunction play a key role in the onset and progression of Parkinson's disease (PD), one of the most common and severe neurodegenerative diseases. However, changes of cellular and molecular immune parameters under development of PD are still little defined. The work is devoted to the analysis of immune cell populations (monocytes, T and B cells and their subtypes), expression of Toll-like receptors (TLR) and spontaneous and mitogen-induced production of pro- and anti-inflammatory cytokines in the peripheral blood of patients at different stages of idiopathic PD and healthy individuals. It is shown that the stage II of PD is characterized by a decrease in the amount of CD3+ T cells, an increase in TLR2 expression on CD4+CD25+ Tregs, as well as an increase in the spontaneous production of proinflammatory cytokines IFNγ and IL-17A. Stage III of PD is associated with a decrease in the production of mitogen-induced IFNγ. The relative number of CD19+CD25+ Breg cells in patients with PD increased regardless of the disease stage. Thus, the obtained results indicate differences in cellular and molecular immune parameters existing in patients with PD and in healthy individuals, which are dependent on the stage of the disease. These data are important for understanding the molecular basis of PD development and prognosis of its course, and may be useful in identifying biomarkers of disease severity and developing new treatment approaches depending on the stage of the disease.

Biohimiâ. 2025;90(3):403-413
pages 403-413 views
Activation of bacterial F-ATPase by LDAO: deciphering the molecular mechanism
Bruman S., Zubareva V., Shugaeva T., Lapashina A., Feniouk B.
Resumo

Proton FOF1-ATP synthase catalyzes the formation of ATP from ADP and inorganic phosphate coupled with transmembrane proton transfer using the energy of the proton motive force (pmf). As pmf falls, the direction of the reaction is reversed and the enzyme generates pmf, transferring protons across the membrane using the energy of ATP hydrolysis. The ATPase activity of the enzyme can be suppressed by ADP in a non-competitive manner (ADP-inhibition), and in a number of bacteria can be inhibited by the conformational changes of subunit ε regulatory C-terminal domain. Lauryldimethylamine oxide (LDAO), a zwitterionic detergent, is known to attenuate both aforementioned inhibitory mechanisms, stimulating a significant increase in the enzyme's ATPase activity. For this reason, LDAO is sometimes used for the semi-quantitative estimation of these regulatory mechanisms. However, the binding site of LDAO on ATP synthase remains unknown. The mechanism by which the detergent counteracts ADP-inhibition and inhibition by the ε subunit is also unclear. We performed molecular docking and predicted that LDAO binding might occur at the catalytic sites of ATP synthase, whether empty or containing nucleotides. Molecular dynamics simulations showed that LDAO could affect the mobility of a loop in the β subunit (residues β404-415 in Escherichia coli ATP synthase) near the catalytic site. Mutagenesis of the β409 residue in E. coli enzyme and the corresponding β419 residue in Bacillus subtilis ATP synthase revealed that the side chain type of this residue indeed affects LDAO-dependent stimulation of ATPase activity. We also found that LDAO activates the enzyme more strongly in the presence of 100 mM sulfate compared to sulfate-free media. This phenomenon is likely due to the enhancement of ADP-inhibition of the enzyme by sulfate.

Biohimiâ. 2025;90(3):414-429
pages 414-429 views
Mavacamten inhibits the effect of the N-terminal fragment of cardiac myosin-binding protein-C with the L352P mutation on actin-myosin interaction at low calcium concentrations
Kochurova A., Beldiia E., Antonets J., Nefedova V., Ryabkova N., Katrukha I., Bershitsky S., Matyushenko A., Kopylova G., Shchepkin D.
Resumo

Mutations in sarcomeric proteins associated with hypertrophic cardiomyopathy (HCM) lead to disruption of actin-myosin interaction, its calcium regulation, and myocardial hypercontractility. About half of such mutations are found in the MYBPC3 gene encoding cardiac myosin binding protein C (cMyBP-C). A new approach to normalize cardiac contractile function in HCM is the use of inhibitors of β-cardiac myosin function, one of which is mavacamten. We studied the effect of mavacamten on calcium regulation of actin-myosin interaction using isolated cardiac contractile proteins in an in vitro motility assay. The L352P mutation did not affect the maximum sliding velocity of regulated thin filaments on myosin in an in vitro motility assay and the calcium sensitivity of the velocity and led to underinhibition of actin-myosin interaction at low calcium concentrations. Mavacamten decreased the maximum sliding velocity of thin filaments with WT and L352P C0-C2 fragments, and in the presence of L352P C0-C2 fragment stopped their movement at low calcium concentrations. Slowing down the kinetics of cross-bridge and inhibition of actin-myosin interaction at low calcium concentrations in the presence of mavacamten may reduce hypercontractility in HCM and the degree of myocardial hypertrophy.

Biohimiâ. 2025;90(3):430-442
pages 430-442 views
Combined ionizing radiation exposure improves behavioral symptoms and modulates brain innate immune system activity in the Tau P301S mice line
Kokhan V., Ageldinov R., Anokhin P., Shamakina I.
Resumo

Tauopathies are a group of neurodegenerative diseases associated with abnormal phosphorylation and aggregation of the microtubule-associated tau-protein. Currently, there is no pathogenetic treatment for tauopathies, but the process of neuroinflammation that accompanies the diseases appears to be a promising therapeutic target. According to the literature, ionizing radiation (IR) may be one of the effective tools to manage neuroinflammation. Here, we investigated the effects of combined ionizing radiation (γ-quanta and carbon-12 nuclei) on locomotor abilities and markers of microglia activation in the brain of transgenic Tau P301S mice line reproducing tauopathy. Irradiation led to improvement in behavioral symptoms of the mice: increased endurance (in the early symptomatic stage) and enhanced locomotor activity (in the terminal stage). At the same time, irradiation resulted in increased levels of pro-inflammatory and anti-inflammatory cytokines and chemokines in the cerebellum and, to a lesser extent, in the hippocampus of irradiated mice. The obtained data indicate a significant modulating effect of IR on the innate immune system, and also indicate a high potential of radiotherapy as a therapeutic method for the treatment of neurodegeneration.

Biohimiâ. 2025;90(3):443-457
pages 443-457 views
Influence of in situ limited proteolysis of potato virus X on change in the structure of virions according to data small-angle X-ray scattering and tritium labeling
Ksenofontov A., Petoukhov M., Peters G., Arutyunyan A., Baratova L., Arkhipenko M., Nikitin N., Karpova O., Shtykova E.
Resumo

The viral capsids of the potexvirus family are characterized by the presence on the surface of virions of partially disordered N-terminal fragments of proteins of various lengths. The present study is devoted to studying the effect of in situ removal of the N-terminal domain of the coat protein (CP) on the structural organization and physicochemical properties of potato virus X (PVX) virions. The work considers PVX virions containing an intact Ps-form CP, as well as virions including an in situ degraded Pf-form devoid of 19/21 amino acid residues from the N-end (PVXΔN). Synchrotron small-angle X-ray scattering (SAXS), transmission electron microscopy (TEM), tritium bombardment, and several other physicochemical methods were used for the study. Analysis of images obtained using TEM revealed similarities in the architecture of filamentous PVX and PVXΔN virions. SAXS results demonstrated differences in the organization of the capsid of PVX and PVXΔN virions: the latter was characterized by a reduction in the size of ordered regions, indicating partial disruption of the structure of the viral protein framework. In addition, based on the SAXS scattering curves, parameters of the spiral packing of virions in solution were calculated, and structural modeling of particles was performed. Modeling results also indicate changes in the structure of the capsid due to the removal of the ΔN-peptide. Using information about the secondary structure of the PVX model (PDB ID: 6R7G) and data from our previous studies on tritium labeling of surface sites of PVX and PVXΔN virions, a comparative analysis of label incorporation profiles into elements of the protein's secondary structure was conducted. This approach made it possible to predict the localization of the ΔN-peptide above the amino acid residues of neighboring helical subunits (122-129 and 143-153) and demonstrate the stabilizing role of this peptide on the overall structure of the virion. An increase in the level of the label in the C-terminal region after removing the ΔN-peptide also indicates a decrease in the compactness of the virion. Overall, the knowledge gained will be useful when using virus-like nanoparticles in biotechnology.

Biohimiâ. 2025;90(3):458-470
pages 458-470 views
Endocytosis features of GD2-specific antibodies of different formats in tumor cells
Makarova A., Titov M., Kalinovsky D., Kholodenko I., Kibardin A., Larin S., Svirshchevskaya E., Deyev S., Kholodenko R.
Resumo

Antibody-drug conjugates (ADCs) have emerged as one of the most promising classes of monoclonal antibody-based (mAb) targeted cancer therapies. To date, 15 drugs of this class have been approved for clinical use, while many more are undergoing more than 100 clinical trials. Similarly to unconjugated antibodies, ADCs target various tumor markers including carbohydrate antigens in glycosphingolipids. Among them, ganglioside GD2 is considered the most promising marker, and recent studies have shown significant potential for the use of anti-GD2 ADCs. Receptor internalization after antigen-antibody complex formation and its transport to cell lysosomes are important characteristics of the marker, on which the effectiveness of ADCs largely depends. The ability of GD2-specific antibodies to internalize and the mechanisms of endocytosis of their complexes with GD2 have been poorly studied. The study investigated the mechanisms of internalization of ganglioside GD2 complexes and the most relevant GD2-specific antibodies of various formats, including full-length antibodies, minibodies, and scFv fragments. It was demonstrated that all the antibody variants used are capable of internalizing into GD2-positive tumor cells and entering their lysosomal compartments. Full-length antibodies and minibodies demonstrate high efficiency of endocytosis in GD2-positive cells, which occurs through several pathways, primarily macropinocytosis and caveolae-mediated endocytosis. The obtained data may be of interest for development of more effective targeted drugs for the treatment of GD2-positive tumors.

Biohimiâ. 2025;90(3):471-484
pages 471-484 views

Согласие на обработку персональных данных с помощью сервиса «Яндекс.Метрика»

1. Я (далее – «Пользователь» или «Субъект персональных данных»), осуществляя использование сайта https://journals.rcsi.science/ (далее – «Сайт»), подтверждая свою полную дееспособность даю согласие на обработку персональных данных с использованием средств автоматизации Оператору - федеральному государственному бюджетному учреждению «Российский центр научной информации» (РЦНИ), далее – «Оператор», расположенному по адресу: 119991, г. Москва, Ленинский просп., д.32А, со следующими условиями.

2. Категории обрабатываемых данных: файлы «cookies» (куки-файлы). Файлы «cookie» – это небольшой текстовый файл, который веб-сервер может хранить в браузере Пользователя. Данные файлы веб-сервер загружает на устройство Пользователя при посещении им Сайта. При каждом следующем посещении Пользователем Сайта «cookie» файлы отправляются на Сайт Оператора. Данные файлы позволяют Сайту распознавать устройство Пользователя. Содержимое такого файла может как относиться, так и не относиться к персональным данным, в зависимости от того, содержит ли такой файл персональные данные или содержит обезличенные технические данные.

3. Цель обработки персональных данных: анализ пользовательской активности с помощью сервиса «Яндекс.Метрика».

4. Категории субъектов персональных данных: все Пользователи Сайта, которые дали согласие на обработку файлов «cookie».

5. Способы обработки: сбор, запись, систематизация, накопление, хранение, уточнение (обновление, изменение), извлечение, использование, передача (доступ, предоставление), блокирование, удаление, уничтожение персональных данных.

6. Срок обработки и хранения: до получения от Субъекта персональных данных требования о прекращении обработки/отзыва согласия.

7. Способ отзыва: заявление об отзыве в письменном виде путём его направления на адрес электронной почты Оператора: info@rcsi.science или путем письменного обращения по юридическому адресу: 119991, г. Москва, Ленинский просп., д.32А

8. Субъект персональных данных вправе запретить своему оборудованию прием этих данных или ограничить прием этих данных. При отказе от получения таких данных или при ограничении приема данных некоторые функции Сайта могут работать некорректно. Субъект персональных данных обязуется сам настроить свое оборудование таким способом, чтобы оно обеспечивало адекватный его желаниям режим работы и уровень защиты данных файлов «cookie», Оператор не предоставляет технологических и правовых консультаций на темы подобного характера.

9. Порядок уничтожения персональных данных при достижении цели их обработки или при наступлении иных законных оснований определяется Оператором в соответствии с законодательством Российской Федерации.

10. Я согласен/согласна квалифицировать в качестве своей простой электронной подписи под настоящим Согласием и под Политикой обработки персональных данных выполнение мною следующего действия на сайте: https://journals.rcsi.science/ нажатие мною на интерфейсе с текстом: «Сайт использует сервис «Яндекс.Метрика» (который использует файлы «cookie») на элемент с текстом «Принять и продолжить».